Some treatments, such as nonsteroidal anti-inflammatory drugs (NSAIDs), can reduce pain short term, but disease-modifying antirheumatic drugs (DMARDs) can slow or stop the long-term progression of ...

RA treatment can help slow the progression of the disease and relieve symptoms. But each medication comes with certain risks and side effects. Rheumatoid arthritis (RA) is an autoimmune ...

Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease that affects ∼0.8% of the adult population worldwide. Onset typically occurs between 30 and 50 years of age, with an ...

inhibitors in patients with rheumatoid arthritis (RA), particularly when used as monotherapy and in those previously treated with at least two biologic disease-modifying antirheumatic drugs ...

For most people with RA and peripheral SpA, we recommend initial treatment with a conventional disease-modifying antirheumatic drug (DMARD), such as methotrexate. For axial SpA we recommend offering a ...